000 | 01814cam a2200325 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
008 | 131225s2013 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aM.Sc | ||
099 | _aCai01.11.07.M.Sc.2013.Ra.S | ||
100 | 0 | _aRaghda Taha Ahmed Mohammad Fouda | |
245 | 1 | 4 |
_aThe specific von willebrand factor-cleaving protease ADAMTS13 activity in childhood HUS in a Pediatric University Hospital in Egypt / _cRaghda Taha Ahmed Mohammad Fouda ; Supervised Azza Ahmed Aboulenein , Mohamed Hesham Safouh , Dalia Gameel Amin |
246 | 1 | 5 | _aفى مستشفى طب الأطفال الجامعى فى مصر HUS فى الاطفال المصابون بمرض ال ADAMTS13 دراسة نشاط إنزيم ال |
260 |
_aCairo : _bRaghda Taha Ahmed Mohammad Fouda , _c2013 |
||
300 |
_a185 P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
520 | _aConsidering the overlapping clinical manifestation of hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP), we hypothesized that ADAMTS13 would be an important factor in discrimination between the two TMAs. The goal of this study was to determine ADAMTS13 activity as well as the presence of inhibitors in children with typical postdiarrheal (D+) or atypical non-post diarrheal (D-) HUS | ||
530 | _aIssued also as CD | ||
653 | 4 | _aADAMTS13 | |
653 | 4 | _aChildren | |
653 | 4 | _aHemolytic uremic syndrome | |
700 | 0 |
_aAzza Ahmed Aboulenein , _eSupervisor |
|
700 | 0 |
_aDalia Gameel Amin , _eSupervisor |
|
700 | 0 |
_aMohamed Hesham Safouh , _eSupervisor |
|
905 |
_aNazla _eRevisor |
||
905 |
_aSamia _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c44603 _d44603 |